Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting. - Baker, Joshua F.; Bakewell, Catherine; Dikranian, Ara; Lam, Gordon; O'Brien, Jacqueline; Moore, Page C.; Yu, Miao; Hur, Peter; Masri, Karim R. (Rheumatology & Therapy, 2024)